Contemporary outcomes of chronic total occlusion percutaneous coronary intervention in Europe: the ERCTO registry.


Journal

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
ISSN: 1969-6213
Titre abrégé: EuroIntervention
Pays: France
ID NLM: 101251040

Informations de publication

Date de publication:
05 Feb 2024
Historique:
medline: 12 2 2024
pubmed: 12 2 2024
entrez: 12 2 2024
Statut: epublish

Résumé

Percutaneous coronary interventions (PCI) of chronic total occlusions (CTO) have reached high procedural success rates thanks to dedicated equipment, evolving techniques, and worldwide adoption of state-of-the-art crossing algorithms. We report the contemporary results of CTO PCIs performed by a large European community of experienced interventionalists. Furthermore, we investigated the impact of different risk factors for procedural major adverse cardiac and cerebrovascular events (MACCE) and trends of employment of specific devices like dual lumen microcatheters, guiding catheter extensions, intravascular ultrasound and calcium-modifying tools. We evaluated data from 8,673 CTO PCIs included in the European Registry of Chronic Total Occlusion (ERCTO) between January 2021 and October 2022. The overall technical success rate was 89.1% and was higher in antegrade as compared with retrograde cases (92.8% vs 79.3%; p<0.001). Compared with antegrade procedures, retrograde procedures had a higher complexity of attempted lesions (Japanese CTO [J-CTO] score: 3.0±1.0 vs 1.9±1.2; p<0.001), a higher procedural and in-hospital MACCE rate (3.1% vs 1.2%; p<0.018) and a higher perforation rate with and without tamponade (1.5% vs 0.4% and 8.3% vs 2.1%, respectively; p<0.001). As compared with mid-volume operators, high-volume operators had a higher technical success rate in antegrade and retrograde procedures (93.4% vs 91.2% and 81.5% vs 69.0%, respectively; p<0.001), and had a lower MACCE rate (1.47% vs 2.41%; p<0.001) despite a higher mean complexity of the attempted lesions (J-CTO score: 2.42±1.28 vs 2.15±1.27; p<0.001). The adoption of different recanalisation techniques, operator experience and the use of specific devices have contributed to a high procedural success rate despite the high complexity of the lesions documented in the ERCTO.

Sections du résumé

BACKGROUND BACKGROUND
Percutaneous coronary interventions (PCI) of chronic total occlusions (CTO) have reached high procedural success rates thanks to dedicated equipment, evolving techniques, and worldwide adoption of state-of-the-art crossing algorithms.
AIMS OBJECTIVE
We report the contemporary results of CTO PCIs performed by a large European community of experienced interventionalists. Furthermore, we investigated the impact of different risk factors for procedural major adverse cardiac and cerebrovascular events (MACCE) and trends of employment of specific devices like dual lumen microcatheters, guiding catheter extensions, intravascular ultrasound and calcium-modifying tools.
METHODS METHODS
We evaluated data from 8,673 CTO PCIs included in the European Registry of Chronic Total Occlusion (ERCTO) between January 2021 and October 2022.
RESULTS RESULTS
The overall technical success rate was 89.1% and was higher in antegrade as compared with retrograde cases (92.8% vs 79.3%; p<0.001). Compared with antegrade procedures, retrograde procedures had a higher complexity of attempted lesions (Japanese CTO [J-CTO] score: 3.0±1.0 vs 1.9±1.2; p<0.001), a higher procedural and in-hospital MACCE rate (3.1% vs 1.2%; p<0.018) and a higher perforation rate with and without tamponade (1.5% vs 0.4% and 8.3% vs 2.1%, respectively; p<0.001). As compared with mid-volume operators, high-volume operators had a higher technical success rate in antegrade and retrograde procedures (93.4% vs 91.2% and 81.5% vs 69.0%, respectively; p<0.001), and had a lower MACCE rate (1.47% vs 2.41%; p<0.001) despite a higher mean complexity of the attempted lesions (J-CTO score: 2.42±1.28 vs 2.15±1.27; p<0.001).
CONCLUSIONS CONCLUSIONS
The adoption of different recanalisation techniques, operator experience and the use of specific devices have contributed to a high procedural success rate despite the high complexity of the lesions documented in the ERCTO.

Identifiants

pubmed: 38343371
pii: EIJ-D-23-00490
doi: 10.4244/EIJ-D-23-00490
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e185-e197

Auteurs

Giuseppe Vadalà (G)

Division of Cardiology, University Hospital "P. Giaccone", Palermo, Italy.

Alfredo R Galassi (AR)

Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, Palermo, Italy.

Gerald S Werner (GS)

Medizinische Klinik I, Klinikum Darmstadt GmbH, Darmstadt, Germany.

George Sianos (G)

Al Qassimi Hospital, Sharjah, United Arab Emirates.

Nicolaus Boudou (N)

Clinique St Augustin, Bordeaux, France.

Roberto Garbo (R)

Maria Pia Hospital, GVM Care & Research, Turin, Italy.

Laura Maniscalco (L)

Division of Cardiology, University Hospital "P. Giaccone", Palermo, Italy.

Alexander Bufe (A)

Helios Klinikum Krefeld, University Witten/Herdecke, Witten, Germany.

Alexander Avran (A)

Centre Hospitalier de Valenciennes, Valenciennes, France.

Gabriele L Gasparini (GL)

Humanitas Research Hospital, IRCSS, Rozzano, Italy.

Eugenio La Scala (E)

Polyclinique Les Fleurs, Ollioules, France.

Andrew Ladwiniec (A)

Department of Cardiovascular Sciences, NIHR Leicester Biomedical Research Centre, Glenfield Hospital, University of Leicester and University Hospitals of Leicester NHS Trust, Leicester, United Kingdom.

Meruzhan Saghatelyan (M)

Erebouni Medical Center, Yerevan, Armenia and Nork-Marash Medical Center (NMMC), Yerevan, Armenia.

Omer Goktekin (O)

Memorial Bahçelievler Hospital, Istanbul, Turkey.

Sevket Gorgulu (S)

Department of Cardiology, Acibadem University Istanbul, Istanbul, Turkey.

Nicolaus Reifart (N)

Goethe-Universität Frankfurt, Frankfurt am Main, Germany.

Pierfrancesco Agostoni (P)

Hartcentrum, Ziekenhuis Netwerk Antwerpen (ZNA) Middelheim, Antwerp, Belgium.

Sudhir Rathore (S)

Frimley Park Hospital, NHS Foundation Trust, Camberley, United Kingdom.

Mohamed Ayoub (M)

University Heart Center NRW, Bad Oeynhausen, Germany.

Michael Behnes (M)

University Medical Centre Mannheim, Mannheim, Germany.

Iskander Atmowihardjo (I)

Department of Cardiology and Angiology, DRK Kliniken Berlin Köpenick, Berlin, Germany.

Mario Iannaccone (M)

San Giovanni Bosco Hospital, ASL Città Torino, Turin, Italy.

Roberto Diletti (R)

Interventional Cardiology, Thoraxcenter, Erasmus MC, Rotterdam, the Netherlands.

Carlo Di Mario (C)

Department of Clinical & Experimental Medicine, Structural Interventional Cardiology Division, Careggi University Hospital, Florence, Italy.

Kambis Mashayekhi (K)

Department of Cardiology and Angiology, University Heart Center, University Freiburg, Freiburg, Germany.
Department of Internal Medicine and Cardiology, Heart Center Lahr, Lahr, Germany.

Classifications MeSH